style="font-size:15px;"> 18 Dey, S.K., Saini, M., Prabhakar, P., and Kundu, S. (2020). Dopamine β hydroxylase as a potential drug target to combat hypertension. Expert Opinion on Investigational Drugs 29 (9): 1043–1057. https://doi.org/10.1080/13543784.2020.1795830.19 Dey, S.K. and Senapati, S. (2021a). in vivo models for obesity and obesity related carcinogenesis. In: Obesity and Cancer (eds. S. Kumar and S. Gupta), 279–300. Singapore: Springer https://doi.org/10.1007/978‐981‐16‐1846‐8_14.
20 Dey, S.K. and Senapati, S. (2021b). Insulin and insulin‐like growth factor‐1 associated cancers. In: Obesity and Cancer (eds. S. Kumar and S. Gupta), 25–48. Singapore: Springer https://doi.org/10.1007/978‐981‐16‐1846‐8_3.
21 Dinarello, C.A. and Pomerantz, B.J. (2001). Proinflammatory cytokines in heart disease. Blood Purification 19 (3): 314–321. https://doi.org/10.1159/000046960.
22 Drager, L.F., Togeiro, S.M., Polotsky, V.Y., and Lorenzi‐Filho, G. (2013). Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. Journal of the American College of Cardiology 62 (7): 569–576. https://doi.org/10.1016/j.jacc.2013.05.045.
23 Epstein, P.R. (2001). Climate change and emerging infectious diseases. Microbes and Infection 3 (9): 747–754. https://doi.org/10.1016/s1286‐4579(01)01429‐0.
24 Esposito, K., Chiodini, P., Colao, A. et al. (2012). Metabolic syndrome and risk of cancer: a systematic review and meta‐analysis. Diabetes Care 35 (11): 2402–2411. https://doi.org/10.2337/dc12‐0336.
25 Fruh, S.M. (2017). Obesity: risk factors, complications, and strategies for sustainable long‐term weight management. Journal of the American Association of Nurse Practitioners 29 (S1): S3–S14. https://doi.org/10.1002/2327‐6924.12510.
26 G. B. D. Obesity Collaborators, Afshin, A., Forouzanfar, M.H. et al. (2017). Health effects of overweight and obesity in 195 countries over 25 years. The New England Journal of Medicine 377 (1): 13–27. https://doi.org/10.1056/NEJMoa1614362.
27 Gallagher, E.J. and LeRoith, D. (2015). Obesity and diabetes: the increased risk of cancer and cancer‐related mortality. Physiology Reviews 95 (3): 727–748. https://doi.org/10.1152/physrev.00030.2014.
28 Gill, H., Mugo, M., Whaley‐Connell, A. et al. (2005). The key role of insulin resistance in the cardiometabolic syndrome. The American Journal of Medical Sciences 330 (6): 290–294. https://doi.org/10.1097/00000441‐200512000‐00006.
29 Gregor, M.F. and Hotamisligil, G.S. (2011). Inflammatory mechanisms in obesity. Annual Review of Immunology 29: 415–445. https://doi.org/10.1146/annurev‐immunol‐031210‐101322.
30 Grieger, J.A., Hutchesson, M.J., Cooray, S.D. et al. (2021). A review of maternal overweight and obesity and its impact on cardiometabolic outcomes during pregnancy and postpartum. Therapeutic Advances in Reproductive Health 15: 2633494120986544. https://doi.org/10.1177/2633494120986544.
31 Grivennikov, S.I. and Karin, M. (2011). Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Annals of Rheumatic Diseases 70 (Suppl 1): i104–i108. https://doi.org/10.1136/ard.2010.140145.
32 Grundy, S.M. (2016). Metabolic syndrome update. Trends in Cardiovascular Medicine Trends 26 (4): 364–373. https://doi.org/10.1016/j.tcm.2015.10.004.
33 Gupta, R., Mohan, I., and Narula, J. (2016). Trends in coronary heart disease epidemiology in India. Annals of Global Health 82 (2): 307–315. https://doi.org/10.1016/j.aogh.2016.04.002.
34 Han, K.‐T., Cho, G.J., and Kim, E.H. (2018). Evaluation of the association between gestational diabetes mellitus at first pregnancy and cancer within 10 years postpartum using National Health Insurance Data in South Korea. International Journal of Environmental Research and Public Health 15 (12): 2646. https://doi.org/10.3390/ijerph15122646.
35 Hruby, A. and Hu, F.B. (2015). The epidemiology of obesity: a big picture. PharmacoEconomics 33 (7): 673–689. https://doi.org/10.1007/s40273‐014‐0243‐x.
36 Johnson, J.C., Urcuyo, J., Moen, C., and Stevens, D.R. 2nd. (2019). Urban heat island conditions experienced by the Western black widow spider (Latrodectus hesperus): extreme heat slows development but results in behavioral accommodations. PLoS One 14 (9): –e0220153. https://doi.org/10.1371/journal.pone.0220153.
37 Kallio, K.A., Hätönen, K.A., Lehto, M. et al. (2015). Endotoxemia, nutrition, and cardiometabolic disorders. Acta Diabetologica 52 (2): 395–404. https://doi.org/10.1007/s00592‐014‐0662‐3.
38 Kim, E.J. (2016). U.S. Global Change Research Program: the impacts of climate change on human health in the United States: a scientific assessment. Journal of the American Planning Association 82 (4): 418–419. https://doi.org/10.1080/01944363.2016.1218736.
39 Kim, H. and Grafakos, S. (2019). Which are the factors influencing the integration of mitigation and adaptation in climate change plans in Latin American cities? Environmental Research Letters 14: 105008. https://doi.org/10.1088/1748‐9326/ab2f4c.
40 Kirk, E.P. and Klein, S. (2009). Pathogenesis and pathophysiology of the cardiometabolic syndrome. The Journal of Clinical Hypertension (Greenwich) 11 (12): 761–765. https://doi.org/10.1111/j.1559‐4572.2009.00054.x.
41 Koene, R.J., Prizment, A.E., Blaes, A., and Konety, S.H. (2016). Shared risk factors in cardiovascular disease and cancer. Circulation 133 (11): 1104–1114. https://doi.org/10.1161/CIRCULATIONAHA.115.020406.
42 Kumar, R., Singh, M.C., Singh, M.C. et al. (2006). Urbanization and coronary heart disease: a study of urban‐rural differences in northern India. Indian Heart Journal 58 (2): 126–130. https://europepmc.org/article/med/18989056.
43 Kundu, S., Thelma, B.K., Maulik, S.K. et al. (2019a). Novel anti‐hypertensive
